MC
CVS icon

Martin & Co’s CVS Health CVS Stock Holding History

Martin & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,046
Closed -$1.01M – 119
2020
Q1 		$1.01M Buy
17,046
+272
+2% +$18.2K 0.36% 98
2019
Q4 		$1.25M Buy
16,774
+455
+3% +$31.9K 0.36% 97
2019
Q3 		$1.03M Sell
16,319
-1,975
-11% -$117K 0.31% 105
2019
Q2 		$997K Sell
18,294
-480
-3% -$25.8K 0.3% 103
2019
Q1 		$1.01M Buy
18,774
+20
+0.1% +$1.23K 0.31% 107
2018
Q4 		$1.23M Sell
18,754
-105
-0.6% -$7.84K 0.43% 91
2018
Q3 		$1.49M Sell
18,859
-200
-1% -$14.3K 0.45% 87
2018
Q2 		$1.23M Sell
19,059
-46
-0.2% -$3.03K 0.39% 93
2018
Q1 		$1.19M Sell
19,105
-15
-0.1% -$1.08K 0.4% 95
2017
Q4 		$1.39M Buy
19,120
+125
+0.7% +$9.09K 0.44% 91
2017
Q3 		$1.54M Sell
18,995
-1,500
-7% -$119K 0.5% 87
2017
Q2 		$1.65M Buy
20,495
+700
+4% +$55.3K 0.51% 80
2017
Q1 		$1.55M Buy
+19,795
New +$1.58M 0.49% 78

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Martin & Co's CVS Position: Q2 2020 in Review

Martin & Co sold out of CVS Health (CVS) in Q2 2020, closing a stake of 17,046 shares — an estimated $1.01M sold.

Martin & Co first reported a position in CVS in Q1 2017 and held it in 13 quarters. The position peaked at $1.65M in Q2 2017. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Martin & Co reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Martin & Co sold 17,046 CVS Health shares in Q2 2020, an estimated $1.01M.
  • Martin & Co first reported a position in CVS Health in Q1 2017 and held it in 13 quarters.
  • Martin & Co's CVS Health position peaked at $1.65M in Q2 2017.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Martin & Co's 13F filing for Q2 2020, filed 14 Aug 2020.